Choose a country to view content specific to your location
Choose a country to view content specific to your location
EDDP (2-ethylidene-1, 5-dimethyl-3, 3-diphenylpyrrolidine) is the metabolite of methadone, and testing for EDDP is used to determine the effective intake of Methadone when it is used as patient substitution treatment during use cessation. Methadone metabolizes in the liver into EDDP and EMDP. However, the rates of metabolism vary between individuals. The detection of EDDP in place of Methadone avoids the problems related to the metabolic differences of each person.
Contact us to learn more about Meridian’s molecular or immunoassay reagent portfolio. We want to hear from you!
Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!
By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Contact Us” page you agree to the transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be governed by our Privacy Statement.
| Type |
|---|
| Format |
| Host/Source |
| Isotype |
| Tested Apps |
| Unit |
| Catalog |
| Buffer |
| Immunogen |
| COFA Description |
| COFA Notes |
| Recombination |
| SDS |
| COA |
| Product Information Sheet |
| Request Sample |
